Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...
Layalina Privee ليالينا بريفيه on MSN15 天
Fujifilm unveils advanced early detection solutions at Arab Health 2025
Fujifilm Middle East and Africa, part of the globally renowned Fujifilm Corporation, participates at Arab Health 2025, taking place between 27 and 30 January at Dubai World Trade Centre. The company ...
Empowering medical professionals with the latest imaging technologies in early screening, detection, and diagnostics ...
Fujifilm Middle East and Africa part of the globally renowned Fujifilm Corporation is participating at Arab Health 2025 taking place between 27th a ...
Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...
AI decision support system non-homogenously influences clinical decisions in dynamic treatment regimen, as it depends on several factors including prior knowledge, preference, disease type ...
Safety, efficacy, and outcomes of 90-yttrium radioembolization in combination with immune checkpoint inhibitors as a definitive first-line treatment approach in non-surgical hepatocellular carcinoma.
(JAMA Network Open) A single-center trial favored non-contrast MRI over ultrasound for hepatocellular carcinoma (HCC) surveillance in patients with cirrhosis. (Gastroenterology) And for ...
aDepartment of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China bDepartment of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China ...
HCC cell lines (Hepa1-6 and Huh7) were purchased from Servicebio Technology Co ... Finally, fluorescence microscopy (Nikon) was employed to determine the number of TUNEL-positive cells after magnified ...
Despite technical improvements in all modes of HCC diagnostic imaging, difficulties remain in accurately identifying small (< 2 cm) lesions on the background of cirrhosis in all imaging modalities.